Kalcipos-D

Colecalciferol, the active ingredient in Kalcipos-D, is a nutritional supplement presented as an oral dosage form for oral use. It provides vitamin D together with calcium to prevent deficiencies and support bone health in adults, children and the elderly.

GNH USA supplies Kalcipos-D as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows EU quality standards and offers reliable global logistics.

Kalcipos-D is used as a nutritional supplement to address deficiencies in calcium and vitamin D and to promote skeletal health. - Calcium deficiency: helps restore adequate calcium levels and supports normal physiological functions. - Vitamin D deficiency: supplies colecalciferol to maintain sufficient serum 25‑hydroxyvitamin D concentrations. - Bone health support: contributes to bone mineralisation and reduces risk of osteomalacia or osteopenia in at‑risk populations.

Kalcipos-D is generally well tolerated, but some users may experience mild reactions.

Common Side Effects: - Nausea: occasional mild stomach upset. - Constipation: reduced bowel movements. - Abdominal discomfort: mild cramps or bloating. - Headache: transient mild headache. - Dry mouth: sensation of oral dryness. - Mild hypercalcemia: slightly elevated calcium levels without symptoms.

Serious or Rare Side Effects: - Hypercalcemia with symptoms: severe nausea, vomiting, confusion, or cardiac arrhythmia. - Kidney stones: due to excessive calcium excretion. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe hypervitaminosis D: profound hypercalcemia requiring medical attention. - Hypersensitivity anaphylaxis: rare but life‑threatening systemic reaction.

Before using Kalcipos-D, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Renal impairment: monitor calcium levels and renal function. - Existing hypercalcemia: avoid if serum calcium is already elevated. - Concomitant medications: review all current drugs for potential interactions. - Storage: Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Kalcipos-D may interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Thiazide diuretics: can increase calcium retention leading to hypercalcemia. - High‑dose vitamin A supplements: risk of hypervitaminosis D. - Certain antacids containing aluminum or magnesium: may reduce calcium absorption.

Moderate Interactions (Monitor Closely): - Bisphosphonates: calcium may interfere with absorption; separate dosing by at least 2 hours. - Corticosteroids: may affect calcium balance; monitor bone health. - Loop diuretics: increase calcium excretion; watch serum levels.